Skip to content

Combined Saphenous Nerve and IPACK Blocks Versus Infiltration Analgesia After Anterior Cruciate Ligament Reconstruction

Analgesic Efficacy of a Combined Saphenous Nerve Block and IPACK Block Versus Local Infiltration Analgesia After Anterior Cruciate Ligament Reconstruction: a Randomized Controlled Double-blinded Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03680716
Enrollment
60
Registered
2018-09-21
Start date
2018-11-01
Completion date
2020-10-01
Last updated
2021-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anterior Cruciate Ligament Injury, Anterior Cruciate Ligament Rupture, Postoperative Pain

Brief summary

A lot of patient have posterior knee pain after ACL reconstruction despite saphenous nerve block. Recently a new block has been described, know as IPACK block (interspace between the popliteal artery and the capsule of the posterior knee). The objective of this randomized controlled double-blinded trial is to assess whether a combined saphenous nerve block with IPACK block is more effective for the postoperative pain than a local infiltration analgesia.

Detailed description

The saphenous nerve and the iPACK will be performed after general anaesthesia induction and before the surgery under ultrasound-guidance. The local infiltration analgesia will be performed by the surgeon during the surgery.

Interventions

DRUGRopivacaine injection

Saphenous nerve block with 20ml of ropivacaine 0.5% and IPACK block with 30ml of ropivacaine 0.2% (total dose of 160 mg).

Sponsors

Centre Hospitalier Universitaire Vaudois
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Statut ASA I-III. * Patient scheduled for anterior crutiate ligament reconstruction under general anesthesia.

Exclusion criteria

* Pregnancy. * Contraindication to local anesthesia. * Patient with chronic pain, opioid consumption or alcohol consumption. * Patient with coagulation trouble, hepatic dysfunction or renal dysfunction. * Patient with diabetic or femoral neuropathy.

Design outcomes

Primary

MeasureTime frame
Total morphine consumption (mg)24 hours postoperatively

Secondary

MeasureTime frameDescription
Pain scores (numeric rating scale, 0-10) at rest and on movement2hours, 24hours, 48hours and 72hours postoperatively0= no pain, 10=the worst pain imaginable
Rate of postoperative nausea and vomiting2hours, 24hours, 48hours and 72hours postoperativelyYes/No
Rate of antiemetic consumption2hours, 24hours, 48hours and 72hours postoperativelyYes/No
Rate of pruritus2hours, 24hours, 48hours and 72hours postoperativelyYes/No
Total morphine consumption (mg)2 hours, 48 hours and 72 hours postoperatively
Quadriceps muscle strength (numeric scale, 1-5)24hours, 48hours and 72hours postoperatively1=no contraction, 5=normal strength
Distance walked (meters)24 hours, 48hours and 72hours postoperatively
Anterior Cruciate Ligament - Return to Sport after Injury survey4 and 8 postoperative months
International Knee Documentation Committee score4 and 8 postoperative months
Active flexion24hours, 48hours and 72hours postoperativelyFlexion of the knee by the patient measured in degrees

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026